CAS number index
Every CAS Registry Number in our catalogue, sorted numerically. Paste a CAS No. into the search bar to jump straight to the product.
| CAS No. | Substance | Grades |
|---|---|---|
| 16533-45-2 | 2-(Ethoxycarbonyl)-6-nitrobenzoic acid | 1 |
| 16533-48-5 | Ascorbic Acid EP Impurity C | 1 |
| 16533-71-4 | 3,5-Dinitro-p-toluic acid, 98% | 1 |
| 16536-62-2 | N-Benzyl-N,N-dimethyl-1- phenylmethanaminium bromide | 1 |
| 16543-55-8 | N-Nitrosonornicotine | 1 |
| 16555-60-5 | 2-(2-Chlorobenzamido)acetic acid | 1 |
| 16561-29-8 | Phorbol 12-myristate 13-acetate, 98% | 1 |
| 16564-43-5 | Sodium glycochenodeoxycholate, >99% | 1 |
| 16567-04-7 | Pyridoxine N- Oxide | 1 |
| 16574-04-2 | 21-Dehydrocortisone | 1 |
| 16574-43-9 | Bromopyrogallol red, 70% | 2 |
| 16590-41-3 | Naltrexone | 1 |
| 16593-81-0 | PAR, indicator, 99%+ | 4 |
| 16595-80-5 | Levamisole | 1 |
| 16596-04-6 | N,N'-Bis(2,4-xylyl)formamidine | 1 |
| 16600-22-9 | Ethyl 7-chloro-4-hydroxyquinoline-3-carboxylate | 1 |
| 16606-55-6 | (R)-Propylene carbonate, 98% | 1 |
| 16611-15-7 | 4-Chloro-2-nitrodiphenylamine | 1 |
| 16614-60-1 | Buprenorphine EP Impurity C | 1 |
| 16617-07-5 | Naltrexone EP Impurity J | 1 |
| 16617-46-2 | 3-Amino-4-cyanopyrazole, LR | 2 |
| 16627-68-2 | 1,1,2,2-Tetrafluoroethyl 2,2,3,3-tetrafluoropropyl ether, 95% | 1 |
| 16629-19-9 | 2-Thiophenesulphonyl chloride, 96% | 1 |
| 16630-52-7 | 3-(Methylthio)butanal, 96% | 1 |
| 16647-80-6 | 1-Deoxy-L-idonojirimycin | 1 |
| 16652-71-4 | L-Proline Benzyl Ester Hydrochloride | 1 |
| 16653-88-6 | 3-Epismilagenin | 1 |
| 16654-89-0 | Butylated Hydroxytoluene(Sodium Salt) | 1 |
| 16669-06-0 | Dienogest EP Impurity H | 1 |
| 16672-87-0 | 2-Chloroethylphosphonic acid, ≥96% | 2 |
| 16673-34-0 | Glibenclamide - Impurity A | 1 |
| 16674-78-5 | Magnesium acetate, for molecular biology, 99%+ | 3 |
| 16676-29-2 | Naltrexone Hydrochloride | 1 |
| 16676-33-8 | 6-Keto Nalbuphine | 1 |
| 16676-34-9 | 6-Ketonalbuphine Hydrochloride | 1 |
| 16677-29-5 | Z-O-Benzyl-L-tyrosine, 98%+ | 1 |
| 16679-58-6 | Desmopressin | 1 |
| 16680-47-0 | Equilin 3-Sulfate Sodium Salt | 1 |
| 16680-48-1 | Equilenin Sulfate Sodium Salt | 1 |
| 16680-49-2 | 17beta-Dihydroequilin Sodium Sulfate | 1 |
| 16680-50-5 | 17-β-Dihydro Equilenin 3-Sulfate Sodium Salt | 1 |
| 16681-56-4 | 2-Bromo-1H-imidazole, 97% | 1 |
| 16682-12-5 | D-Ornithine Monohydrochloride | 1 |
| 16684-06-3 | Clindamycin EP Impurity C | 1 |
| 16691-79-5 | 2,5-Bis(methoxycarbonyl)-3,4-diphenylcyclopentadienone, 96% | 1 |
| 16694-18-1 | 4-Bromo-2-thiophene carboxylic acid, 98% | 1 |
| 16698-35-4 | Beta-Tocopherol | 1 |
| 16699-20-0 | (E)-1-Benzhydryl-4-cinnamylpiperazine | 1 |
| 16704-47-5 | Vortioxetine Impurity 16 | 1 |
| 16711-66-3 | Cholesterol, cis-9-hexadecenoate | 1 |
| 16711-91-4 | Fusidic Acid EP Impurity H | 1 |
| 16713-66-9 | 3,3-Tetramethyleneglutaric acid | 1 |
| 16727-66-5 | Lincomycin Hydrochloride Impurity | 1 |
| 16729-22-9 | Vitamin A EP Impurity C | 1 |
| 16731-55-8 | Potassium metabisulphite, 95% | 4 |
| 16739-20-1 | 3-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide | 1 |
| 16739-21-2 | 3,5-Dichloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide | 1 |
| 16747-25-4 | 2,2,3-Trimethyl Hexane | 1 |
| 16747-32-3 | 2,2-Dimethyl-3-ethylpentane | 1 |
| 16747-44-7 | 2,2,3,3,4-Pentamethylpentane | 1 |
| 16750-63-3 | 2-Methoxyphenylmagnesium bromide solution 1.0 M in THF | 1 |
| 16752-77-5 | Methomyl | 1 |
| 16758-34-2 | Phenyl 1-thio-β-D-galactopyranoside, 95% | 1 |
| 16758-87-5 | Etifoxine Desmethyl impurity | 1 |
| 16773-42-5 | Ornidazole | 1 |
| 16773-51-6 | 2-Methyl-4-nitro-1-(oxiran-2-ylmethyl)-1H-imidazole | 1 |
| 16773-52-7 | 2-Methyl-5-nitro-1-(2-oxiranylmethyl)-1H-imidazole | 1 |
| 16774-21-3 | Ammonium ceric nitrate, 99% | 3 |
| 16776-76-4 | 3,7-Dihydro-1H,5H-benzo[1,2-c:4,5-c']difuran-1,5-dione | 1 |
| 16783-97-4 | 3-Formyl-Desacetyl Rifapentine | 1 |
| 16783-99-6 | 25 - Desacetyl Rifampicin | 1 |
| 16809-53-3 | 2-(6-Hydroxythymoxy)ethyl dimethylamine hydrochloride | 1 |
| 16817-43-9 | 5-Bromo-2-chloroanisole, 98% | 1 |
| 16819-79-7 | 2`-Ethylpropiophenone | 1 |
| 16828-11-8 | Aluminium Sulphate Purified Hexadecahydrate, 98% | 3 |
| 16830-15-2 | Asiaticoside | 1 |
| 16837-52-8 | Oxymatrine, 98% | 1 |
| 16839-98-8 | Atropine EP Impurity B | 1 |
| 16846-24-5 | Josamycin | 1 |
| 16846-34-7 | Josamycin EP Impurity H | 1 |
| 16851-82-4 | 1-(Benzenesulfonyl)pyrrole, 98% | 1 |
| 16853-85-3 | Lithium aluminium hydride solution, 1.0 M in THF | 5 |
| 16856-18-1 | L-Arginine Alpha-ketoglutarate | 1 |
| 16858-01-8 | Tris(2-pyridylmethyl)amine | 1 |
| 16859-59-9 | 3-Hydroxy-1(3H)-isobenzofuranone | 1 |
| 16860-43-8 | Phenylbutazone EP Impurity B | 1 |
| 16867-03-1 | 2-Amino-3-hydroxypyridine, 98% | 1 |
| 16871-71-9 | Zinc silicofluoride, 99% | 2 |
| 16871-90-2 | Potassium silicofluoride, 98% | 1 |
| 16872-11-0 | Fluoboric acid, 40% | 1 |
| 16873-13-5 | Tetraethylammonium hydrogen sulphate | 3 |
| 16874-12-7 | L-Tyrosine tert-Butyl Ester | 1 |
| 16874-33-2 | 2-Tetrahydrofuroic Acid | 1 |
| 16882-23-8 | 4-Methoxy-3-methylphenylacetone | 1 |
| 16883-48-0 | trans,cis-1,2,4-Trimethylcyclopentane | 1 |
| 16893-85-9 | Sodium fluorosilicate, 99% | 2 |
| 16896-82-5 | Meclozine Hydrochloride EP Impurity E | 1 |
| 16899-81-3 | Isoprenaline EP impurity A Hydrochloride | 1 |
| 16899-83-5 | N-Methyl Adrenalone Hydrochloride | 1 |
| 16903-35-8 | Chloro auric acid (30% in HCl) (Gold Chloride Solution), LR | 2 |
| 16905-14-9 | Potassium iodo platinate, 99.9% | 2 |
| 16908-47-7 | Dipyridamole EP Impurity B | 1 |
| 16915-70-1 | Nifursol | 1 |
| 16919-19-0 | Ammonium hexafluorosilicate, 98% | 1 |
| 16919-27-0 | Potassium titanium fluoride, 98% | 2 |
| 16919-58-7 | Ammonium hexachloroplatinate, 99% | 1 |
| 16921-30-5 | Potassium chloroplatinate (40% Pt) | 2 |
| 16923-95-8 | Potassium Hexafluorozirconate, pure | 1 |
| 16925-39-6 | Calcium fluorosilicate, 95% | 2 |
| 16927-00-7 | 2-(2-Chloroethyl)pyridine | 1 |
| 16929-60-5 | Guaifenesin EP Impurity D | 1 |
| 16932-45-9 | 2-Bromo-1,3-dimethoxybenzene, 98% | 1 |
| 16937-99-8 | Boc-d-leucine, 99% | 1 |
| 16940-66-2 | Sodium borohydride, ≥98.5% | 4 |
| 16940-81-1 | Hexafluorophosphoric acid, AR | 3 |
| 16941-11-0 | Ammonium hexafluorophosphate | 1 |
| 16941-12-1 | Chloroplatinic acid | 1 |
| 16941-32-5 | Glucagon | 1 |
| 16948-63-3 | Dichloro Diazoxide Impurity | 1 |
| 16949-15-8 | Lithium borohydride, ≥95% | 3 |
| 16960-16-0 | Cosyntropin | 1 |
| 16961-25-4 | Gold(III) chloride, trihydrate, 99.9% | 2 |
| 16961-83-4 | Fluosilicic acid | 1 |
| 16968-19-7 | 2,2'-Dinitrodibenzyl | 1 |
| 16974-42-8 | Sotalol EP Impurity A | 1 |
| 16974-44-0 | Deshydroxy Sotalol Hydrochloride | 1 |
| 16978-57-7 | Dexamethasone meta-sulfobenzoate | 1 |
| 16980-89-5 | Adenosine 3ʹ,5ʹ-cyclic monophosphate, ≥98% (HPLC), powder | 2 |
| 16981-20-7 | Mesuol | 1 |
| 16982-21-1 | Ethyl Thiooxamate | 1 |
| 16982-40-4 | Dipyridamole EP Impurity A | 1 |
| 16985-05-0 | Bisacodyl EP Impurity B | 1 |
| 16985-07-2 | 2,2'-(Pyridin-2-ylmethylene)diphenol | 1 |
| 17013-01-3 | Sodium fumarate, 98% | 2 |
| 17017-21-9 | 3,4-O-Isopropylideneepilincomycin | 1 |
| 17017-22-0 | Lincomycin EP Impurity D | 1 |
| 17019-92-0 | 11-Keto beta-Boswellic Acid | 1 |
| 17022-31-0 | Valproic Acid Ethyl Ester | 1 |
| 17025-47-7 | Phenyl tribromomethyl sulphone, 97% | 1 |
| 17026-42-5 | (+)-2,3-Dibenzoyl-D-tartaric acid, ≥98% | 1 |
| 17026-85-6 | Potassium cetyl phosphate | 1 |
| 17027-50-8 | Carglumic Acid Related Compound A | 1 |
| 17079-18-4 | 2,3-Piperidinedicarboxylic acid | 1 |
| 17082-09-6 | Cinnamoyl chloride, extra pure >96% | 1 |
| 17084-13-8 | Potassium hexafluorophosphate, 98% | 2 |
| 17086-28-1 | Doxycycline Monohydrate | 1 |
| 17090-79-8 | Monensin | 1 |
| 17094-01-8 | L-Sepiapterin | 1 |
| 17094-34-7 | Ethyl pivaloylacetate, 98% | 1 |
| 17103-52-5 | Sulfamethoxazole EP Impurity F | 1 |
| 17104-67-5 | 5,6,7,8-Tetrahydronaphthalene-2-carbonitrile | 1 |
| 17109-49-8 | Edifenphos | 1 |
| 17117-72-5 | (2R,3S)-5-Hydroxy-2-(((4-methylbenzoyl)oxy)methyl)tetrahydrofuran-3-yl 4-methylbenzoate | 1 |
| 17131-51-0 | Ranolazine Impurity-13 | 1 |
| 17131-52-1 | Ranolazine Impurity-14 | 1 |
| 17135-46-5 | Haloperidol Impurity 13 | 1 |
| 17135-74-9 | 1,8-Dibromonaphthalene | 1 |
| 17138-28-2 | Metoprolol Hydroxy Ester Impurity | 1 |
| 17139-64-9 | 4-(Trifluoromethyl)-1,3-benzenediamine | 1 |
| 17140-12-4 | Promazine EP Impurity B | 1 |
| 17140-60-2 | Calcium glucoheptonate | 1 |
| 17140-81-7 | Nitrofurantoin Monohydrate | 1 |
| 17153-20-7 | 3-Methylisoxazole-4-carboxylic Acid | 1 |
| 17157-48-1 | 2-Bromoacetaldehyde | 1 |
| 17159-79-4 | Ethyl 4-oxocyclohexanecarboxylate, 97% | 1 |
| 17166-36-8 | 1,2-Propadienylphosphonic Dichloride | 1 |
| 17169-60-7 | Ferrous glycine sulphate | 1 |
| 17178-10-8 | 2-Methoxyethyl 4-methylbenzenesulfonate | 1 |
| 17178-11-9 | 2-Ethoxyethyl 4-methylbenzene-1-sulfonate | 1 |
| 17183-98-1 | Cyproterone Acetate EP Impurity C | 1 |
| 17184-05-3 | Cyproterone Acetate EP Impurity E | 1 |
| 17184-19-9 | N-Desmethyl Deferiprone | 1 |
| 17190-74-8 | Cinerolone | 1 |
| 17191-70-7 | Temazepam EP impurity D | 1 |
| 17193-29-2 | tert-Butyl (S)-4,5-diamino-5-oxopentanoate | 1 |
| 17193-40-7 | p-Nitrophenylalanine methyl ester hydrochloride, 99% | 1 |
| 17194-00-2 | Barium hydroxide, anhydrous, 94-98% | 2 |
| 17194-82-0 | Atenolol EP Impurity A | 1 |
| 17199-29-0 | S-Mandelic acid, 99% | 1 |
| 17200-29-2 | 5-Chlorobenzoxazole | 1 |
| 17201-43-3 | 4-Cyanobenzyl bromide, 99% | 1 |
| 17210-49-0 | 2-(Dimethylamino)ethyl acetate hydrochloride | 1 |
| 17216-10-3 | Propranolol Impurity C | 1 |
| 17217-76-4 | Ferric citrate, 98% | 1 |
| 17229-14-0 | Ethyl2-(2-chloroethoxy)acetate | 1 |
| 17229-17-3 | ((2-chloroethoxy)methyl)benzene | 1 |
| 17230-88-5 | Danazol | 1 |
| 17234-76-3 | Methylcobalamin Impurity 1 | 1 |
| 17247-58-4 | Cyclobutylmethyl bromide, 97% | 1 |
| 17256-39-2 | (1-Chloropropan-2-yl)dimethylamine hydrochloride | 1 |
| 17272-46-7 | Praseodymium chloride, 99.9% | 1 |
| 17277-91-7 | Hydrochlorothiazide Hydroxy Impurity | 1 |
| 17283-12-4 | 1-(3,4-Dimethyl-phenyl)-propan-1-one | 1 |
| 17289-53-1 | Lidocaine EP Impurity I | 1 |
| 17289-54-2 | Lidocaine EP Impurity I | 1 |
| 17298-37-2 | Propionylcarnitine | 1 |
| 17299-95-5 | 1,5-Dibromo-2,3,4-trifluorobenzene | 1 |
| 17301-30-3 | 3,8-Dimethylundecane | 1 |
| 17302-37-3 | 2,2-Dimethyldecane | 1 |
| 17305-49-6 | Androsta-4,8(14)-diene-3,17-dione | 1 |
| 17311-31-8 | Dioxidine | 1 |
| 17312-64-0 | 2,2-Dimethylundecane | 1 |
| 17316-67-5 | Butafosfan | 1 |
| 17318-03-5 | 3-Fluorophenylmagnesium bromide solution 0.5 M THF | 2 |
| 17318-08-0 | 5-Bromo-1,3-dichloro-2-fluorobenzene, 98% | 1 |
| 17320-10-4 | 4β-Hydroxy Cholesterol | 1 |
| 17321-77-6 | Clomipramine Hydrochloride | 1 |
| 17337-13-2 | 2-Biphenylylisocyanate | 1 |
| 17338-96-4 | 8-Methylxanthine | 1 |
| 17341-93-4 | 2,2,2-Trichloroethyl Chloroformate | 1 |
| 17347-32-9 | 6-Bromobenzothiophene | 1 |
| 17348-59-3 | 2-Isopropoxy-2-methylpropane, 98% | 1 |
| 17349-94-9 | N,N-Didesmethyldiphenhydramine | 1 |
| 17349-96-1 | Orphenadrine EP impurity C | 1 |
| 17357-14-1 | 5-Bromo indoxyl acetate, GR 99% | 1 |
| 17363-08-5 | CORM-A1, ≥95% (NMR) | 1 |
| 17364-16-8 | 1-Palmitoyl-sn-glycero-3-phosphocholine | 1 |
| 17364-52-2 | cis-2-Phenylcyclopropanecarbohydrazide | 1 |
| 17370-41-1 | 5-(1,1-Dioxido-1,2-dithiolan-3-yl)pentanoic Acid | 1 |
| 17372-87-1 | Eosine yellow, water soluble | 3 |
| 17375-41-6 | Ferrous Sulphate Monohydrate | 1 |
| 17388-39-5 | Swertiamarin | 1 |
| 17392-83-5 | (+)-Methyl D-lactate, 98% | 1 |
| 17393-35-0 | 1-Cyclopropyl-2-methylpropan-1-ol | 1 |
| 17395-99-2 | Pomolidamide Impurity RS-12 | 1 |
| 17403-03-1 | Naratriptan Impurity-3 (Stage-1) | 1 |
| 17403-07-5 | Naratriptan Impurity A | 1 |
| 17420-30-3 | 2-Amino-5-nitrobenzonitrile | 1 |
| 17431-55-9 | 7-Epi Clindamycin Hydrochloride | 1 |
| 17440-83-4 | Amiloride Hydrochloride Dihydrate | 1 |
| 17447-35-7 | (2R,3R)-4-((4-Chlorophenyl)amino)-2,3-dihydroxy-4-oxobutanoic acid | 1 |
| 17450-56-5 | Ethyl (E)-4-oxo-4-phenylbut-2-enoate | 1 |
| 17455-13-9 | 18-Crown-6 ether | 2 |
| 17459-92-6 | Bilirubin Diglucuronide | 1 |
| 17460-13-8 | Glucosamine EP Impurity C | 1 |
| 17465-86-0 | γ-Cyclodextrin, ≥98% | 1 |
| 17469-89-5 | N,N-DiMethyl-L-phenylalanine | 1 |
| 17471-10-2 | Dimenhydrinate EP Impurity F | 1 |
| 17476-04-9 | Lithium tri-tert-butoxyaluminum hydride, 1.0 M in THF | 1 |
| 17479-19-5 | Dihydroergotamine EP Impurity E | 1 |
| 17480-08-9 | E-Cinnamylamine Hydrochloride | 1 |
| 17488-25-4 | 1,4-Dichloro-2,5-dinitrobenzene | 1 |
| 17488-50-5 | Atropine Impurity 17 | 1 |
| 17501-44-9 | Zirconium(IV) acetylacetonate, 98% | 1 |
| 17502-86-2 | Methyl 1,2,3,4-Tetrahydro-1-naphthalene- carboxylate | 1 |
| 17510-99-5 | 2-Keto-3-Deoxygluconate | 1 |
| 17512-61-7 | Sertaconazole Nitrate EP Impurity B | 1 |
| 17518-47-7 | Naphazoline Impurity 1 | 1 |
| 17524-05-9 | Molybdenum dioxide bis(acetylacetonate) | 1 |
| 17527-29-6 | 1H,1H,2H,2H-Perfluorooctyl Acrylate | 1 |